That'd be about in line with what I'd figure
Even within the realm of surgical and chronic disease management, I would be surprised if they take a serious look into outcomes. That's why I was surprised by the initial mention of cost efficiency. I would be surprised if they do any legitimate analyses along those lines.
Thinking offhand, doesn't the ACA imposes (A) limits on what payers can use toward non-healthcare areas, (B) require community rating, (C) disallow payers to drop individual's insurance, (D) remove lifetime caps on payer disbursement, and (E) incentivize ACO's?
As I see it, A, B, C and D attempt to address 1 and 2, and E attempts to address 3. I think 4 and 5 were deliberately neglected for political reasons (for the time being). The ACA seems sloppy to me, but it seems like it's making strides in some of the areas you say it isn't. I welcome clarification though